p28(GANK) prevents degradation of Oct4 and promotes expansion of tumor-initiating cells in hepatocarcinogenesis
View abstract on PubMed
Summary
This summary is machine-generated.p28(GANK) protein activates liver tumor-initiating cells (T-ICs) in hepatocellular carcinoma (HCC) by stabilizing Oct4. Targeting p28(GANK) may offer a new strategy to inhibit HCC progression and metastasis.
Area Of Science
- Hepatocellular Carcinoma Research
- Cancer Stem Cell Biology
- Molecular Oncology
Background
- Hepatocellular carcinoma (HCC) is thought to originate from tumor-initiating cells (T-ICs).
- The specific stem cell-like properties of HCC T-ICs remain largely uncharacterized.
- Understanding T-IC biology is crucial for developing effective HCC therapies.
Purpose Of The Study
- To investigate the role of p28(GANK) in the stem cell-like properties of HCC T-ICs.
- To elucidate the molecular mechanisms by which p28(GANK) influences T-IC function.
- To explore the therapeutic potential of targeting p28(GANK) in HCC.
Main Methods
- Quantification of p28(GANK), OV6, and Oct4 in 130 HCC samples via immunohistochemistry.
- Isolation of OV6+ HCC cells using magnetic-activated cell sorting.
- Assessment of T-IC properties through gene expression, flow cytometry, and spheroid formation assays.
- Coimmunoprecipitation to study protein interactions; in vivo studies in mouse models.
Main Results
- High p28(GANK) levels correlated with OV6+ cell expansion and HCC progression.
- p28(GANK) was predominantly expressed in liver T-ICs and undifferentiated HCC spheroids.
- Increased p28(GANK) enhanced T-IC percentages, stem cell gene expression, self-renewal, chemoresistance, tumorigenicity, and metastasis.
- p28(GANK) knockdown reduced T-IC properties; p28(GANK) impedes Oct4 degradation by WWP2.
Conclusions
- p28(GANK) activates and maintains liver T-ICs in HCC by preventing Oct4 degradation.
- Targeting p28(GANK) could be a viable strategy to inactivate T-ICs.
- Inhibiting p28(GANK) may slow hepatocellular carcinoma progression.